CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.

Molecular medicine (Cambridge, Mass.)

Volumn 17, Issue 9-10, 2011, Pages 974-979

  Koppel, Jeremy ^a   Campagne, Fabien ^b   Vingtdeux, Valérie ^b   Dreses Werringloer, Ute ^b   Ewers, Michael ^b   Rujescu, Dan ^b   Hampel, Harald ^b   Gordon, Marc L ^b   Christen, Erica ^b   Chapuis, Julien ^b   Greenwald, Blaine S ^b   Davies, Peter ^b   Marambaud, Philippe ^b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BIOLOGICAL MARKER; CALCIUM CHANNEL; CALHM1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PEPTIDE FRAGMENT; SECRETASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COGNITION; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; APOLIPOPROTEINS E; ASPARTIC ACID ENDOPEPTIDASES; BIOLOGICAL MARKERS; CALCIUM CHANNELS; COGNITION; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

MLCS; MLOWN;

EID: 84858782600     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2011.00154     Document Type: Article

References (0)